Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary
N

Nirmatrelvir + Ritonavir

Availability of ACE Drug Guidance

Yes

Biologics Drug Information Overview

No

Subsidy Information and Financing Scheme

Medical Assistance Fund

Active ingredients: Nirmatrelvir | Ritonavir

General information

Subsidy Information and Financing Scheme

[MAF] Nirmatrelvir & Ritonavir [Paxlovid] Tablets, Nirmatrelvir 150 mg + Ritonavir 100 mg

  1. Additional clinical criteria applies

    Treatment of mild-to-moderate Coronavirus Disease 2019 (COVID-

  2. , within 5 days of symptom onset, in patients who are at high risk for progression to severe COVID-19, including hospitalisation or death.

View legend

Drug Guidance for Subsidy

25/10/2024 Nirmatrelvir and ritonavir combination for treating mild-to-moderate COVID-19

The Ministry of Health’s Drug Advisory Committee has recommended:

  • Nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet combination for treating mild-to moderate Coronavirus Disease 2019 (COVID-19) in patients aged 18 years or older who are immunocompromised.

Funding status

[R] Nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet combination is recommended for inclusion on the Medication Assistance Fund (MAF) for the abovementioned indication from 1 November 2024.

[R] Nirmatrelvir and ritonavir combination should be used in line with the additional clinical criteria listed in the Annex.

View legend

General Availability in Public Healthcare Institution

Note:

General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.

Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration

Availability information

Formulation

Public Healthcare Institution

Paxlovid Tablets, Nirmatrelvir 150 mg + Ritonavir 100 mg

  1. Changi General Hospital

  2. Institute of Mental Health

  3. Khoo Teck Puat Hospital

  4. National Cancer Centre

  5. Sengkang General Hospital

  6. Singapore General Hospital

  7. Tan Tock Seng Hospital

  8. Woodlands Health Campus

Registered Product(s) Information

Clinical and product info

Clinical info

Product Info

Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch.

The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice.

Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information.

Oral

* Clinical information is available for this product.

Back to top